S&P 500 & CVS Health

S&P 500: The S&P 500 notched its ninth straight weekly gain and monthly advance, driven by hopes of progress toward a peaceful resolution to the Iran war and a robust earnings season.

CVS Health: CVS Health>>>'s decision to restore coverage for Zepbound and add Foundayo positively impacted Eli Lilly and Company>>>.

S&P 500: The S&P 500 notched its ninth straight weekly gain and monthly advance, driven by hopes of progress toward a peaceful resolution to the Iran war and a robust earnings season.

CVS Health: CVS Health>>>'s decision to restore coverage for Zepbound and add Foundayo positively impacted Eli Lilly and Company>>>.

S&P 500: The S&P 500 closed at a record high, indicating overall positive market sentiment, partly due to AI optimism and the potential de-escalation of geopolitical tensions.

CVS Health: CVS Health climbed after reporting better-than-expected first-quarter results and raising its full-year financial forecasts.

S&P 500: The S&P 500 has scaled new highs despite rising energy costs and inflation worries, indicating that corporate profits have been buoyant in the first quarter, though margin forecasts are being cut for the second quarter.

CVS Health: Gentell supplies a medical technology firm that provides products to retail stores like CVS Health, indicating a potential indirect impact on CVS Health's supply chain.